The Latest Breaking News from FDA

Government sources had indicated flights would begin in July, but order shows first could happen on 24 June

The disease has spread to poultry in 48 states, dairy cattle in nine, and two people in Texas and Colorado.

Move intended to boost standards and attract recruits from private sector criticised as ‘tinkering’ by FDA union

It is unclear why the suggested rule was not released by its intended deadline. But a spokesperson for the federal agency told NPR that its implementation "continues to be a high priority."

Discover how incorporating yogurt into your diet can help reduce the risk of type 2 diabetes, as approved by the FDA.

FDA allows yogurt producers to claim reduced Type 2 diabetes risk despite limited evidence. Consumers advised to critically evaluate labeling claims.

Samsung already has passive AFib detection of irregular heart rhythm. This new patent will use generative AI to convert PPG data into ECG graphs — and we're intrigued.

"There's not enough profit" for drug-makers in life-saving cancer meds, and the FDA can't force them

Amid increasing healthcare spending, breakthroughs in genomics and personalized medicine, and the adoption of new technologies, the pharma industry is booming. So, let’s analyze Eli Lilly (LLY) and Pfizer (PFE) to determine which pharma stock will surge from their first-quarter earnings. Read on to find out.

The pharmaceutical industry is undergoing rapid growth and expansion, driven by rising medical needs, favorable regulatory measures, and the implementation of pharma 4.0. Hence, investors could snatch up quality pharma stocks Bristol-Myers Squibb (BMY), Spero Therapeutics (SPRO), and OptiNose (OPTN) for steady returns during market dips. Read more.

The FDA has just approved the Apple Watch's AFib feature in a watershed moment for digital health tech.